Wow. He was the one who found and setup the Satipharm acquisition when they had no direction. For him to leave and simply say "I decided in November to move onto my next challenge" signals that things are in really bad shape.
I wonder if the Chief scientific officer will be next.
Ann: S3 Trial update, page-35
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.34M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.8¢ | 3.7¢ | $3.09K | 82.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 1030441 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 125000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| CAN (ASX) Chart |